Compare WWD & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WWD | PCVX |
|---|---|---|
| Founded | 1870 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.2B | 6.0B |
| IPO Year | N/A | 2020 |
| Metric | WWD | PCVX |
|---|---|---|
| Price | $305.11 | $46.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $284.70 | $101.67 |
| AVG Volume (30 Days) | 715.5K | ★ 1.5M |
| Earning Date | 02-02-2026 | 11-04-2025 |
| Dividend Yield | ★ 0.37% | N/A |
| EPS Growth | ★ 19.63 | N/A |
| EPS | ★ 7.19 | N/A |
| Revenue | ★ $3,567,064,000.00 | N/A |
| Revenue This Year | $10.62 | N/A |
| Revenue Next Year | $8.08 | N/A |
| P/E Ratio | $42.55 | ★ N/A |
| Revenue Growth | ★ 7.30 | N/A |
| 52 Week Low | $146.82 | $27.66 |
| 52 Week High | $306.90 | $93.77 |
| Indicator | WWD | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 63.56 | 54.15 |
| Support Level | $286.36 | $42.40 |
| Resistance Level | $301.38 | $45.15 |
| Average True Range (ATR) | 8.32 | 1.95 |
| MACD | -0.80 | -0.30 |
| Stochastic Oscillator | 92.57 | 68.65 |
Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.